Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells

Fei Ting Hsu, Cho Chin Sun, Chia Hsing Wu, Yen Ju Lee, Chih Hung Chiang, Wei Shu Wang

研究成果: 雜誌貢獻文章同行評審

22 引文 斯高帕斯(Scopus)

摘要

The aim of the present study was to verify the effects of regorafenib on apoptosis and metastatic potential in TSGH 8301 human bladder carcinoma cells in vitro. Cells were treated with different concentration of regorafenib for different periods of time. Effects of regorafenib on cell viability, apoptosis pathways, metastatic potential, and expression of metastatic and anti-apoptotic proteins were evaluated with the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay, flow cytometry, cell migration and invasion assay, and western blotting. We found regorafenib significantly reduced cell viability, cell migration and invasion, and expression of metastatic and anti-apoptotic proteins. In addition, regorafenib significantly induced accumulation of sub-G1 phase cells, loss of mitochondrial membrane potential, and expression of active caspase-3 and caspase-8. These results show that regorafenib not only induces apoptosis, but also inhibits metastatic potential in bladder cancer TSGH 8301 cells in vitro.
原文英語
頁(從 - 到)4919-4926
頁數8
期刊Anticancer Research
37
發行號9
DOIs
出版狀態已發佈 - 9月 1 2017

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Regorafenib induces apoptosis and inhibits metastatic potential of human bladder carcinoma cells」主題。共同形成了獨特的指紋。

引用此